Rapt Therapeutics, Inc.
(NASDAQ : RAPT)

( )
RAPT After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc. -1.54%74.761.0%$1996.88m
AMGNAmgen, Inc. -2.76%202.731.3%$918.41m
REGNRegeneron Pharmaceuticals, Inc. 3.23%488.292.6%$828.23m
BIIBBiogen, Inc. 0.08%316.381.5%$752.19m
VRTXVertex Pharmaceuticals, Inc. 2.60%237.951.9%$578.97m
MRNAModerna, Inc. -1.74%29.950.0%$552.86m
ILMNIllumina, Inc. -1.13%273.123.5%$472.89m
ALXNAlexion Pharmaceuticals, Inc. 2.90%89.792.0%$286.71m
AAgilent Technologies, Inc. -1.50%71.581.6%$233.14m
EXASEXACT Sciences Corp. -0.74%58.0021.0%$199.18m
INCYIncyte Corp. 1.47%73.232.5%$179.33m
SGENSeattle Genetics, Inc. 0.08%115.386.1%$169.84m
BMRNBioMarin Pharmaceutical, Inc. 2.44%84.504.3%$164.79m
NVAXNovavax, Inc. -5.04%13.58114.7%$126.80m
ALNYAlnylam Pharmaceuticals, Inc. 0.02%108.858.7%$101.36m

Company Profile

Rapt Therapeutics, Inc. operates as a clinical stage immunology-based biopharmaceutical company. It focuses on discovering, developing and commercializing oral small molecule therapies for patients in oncology and inflammatory diseases.. The company was founded in 2015 and is headquartered in South San Francisco, CA.